BRIEF-AbbVie announces positive pivotal phase 3 data for elagolix
October 19, 2016 at 09:19 AM EDT
* AbbVie announces positive pivotal phase 3 data demonstrating investigational medicine elagolix reduces menstrual and non-menstrual pelvic pain associated with endometriosis at the American Society for reproductive medicine scientific congress